Trajectory modeling of endothelial-to-mesenchymal transition reveals galectin-3 as a mediator in pulmonary fibrosis.
Trajectory modeling of endothelial-to-mesenchymal transition reveals galectin-3 as a mediator in pulmonary fibrosis.
复制标题
DOI:
10.1038/s41419-021-03603-0
复制
发表时间:
2021-03-26
影响因子:
9
通讯作者:
Wu Q
中科院分区:
文献类型:
--
作者:
Jia W;Wang Z;Gao C;Wu J;Wu Q
The endothelial-to-mesenchymal transition (EndMT) is an important source of fibrotic cells in idiopathic pulmonary fibrosis (IPF). However, how endothelial cells (ECs) are activated and how EndMT impact IPF remain largely elusive. Here, we use unsupervised pseudotemporal analysis to recognize the heterogeneity of ECs and reconstruct EndMT trajectory of bleomycin (BLM)-treated Tie2creER/+;Rosa26tdTomato/+ IPF mice. Genes like C3ar1 and Lgals3 (protein name galectin-3) are highly correlated with the transitional pseudotime, whose expression is gradually upregulated during the fate switch of ECs from quiescence to activation in fibrosis. Inhibition of galectin-3 via siRNA or protein antagonists in mice could alleviate the pathogenesis of IPF and the transition of ECs. With the stimulation of human pulmonary microvascular endothelial cells (HPMECs) by recombinant proteins and/or siRNAs for galectin-3 in vitro, β-catenin/GSK3β signaling and its upstream regulator AKT are perturbed, which indicates they mediate the EndMT progress. These results suggest that EndMT is essential to IPF process and provide potential therapeutic targets for vascular remodeling.
登录
查看更多内容
影响因子:
64.8
作者:
Cao, Junyue;Spielmann, Malte;Shendure, Jay
通讯作者:
Shendure, Jay
影响因子:
11.5
作者:
Choi, Seo-Hyun;Hong, Zhen-Yu;Lee, Yoon-Jin
通讯作者:
Lee, Yoon-Jin
影响因子:
16.6
作者:
Dejana E;Hirschi KK;Simons M
通讯作者:
Simons M
影响因子:
9.7
作者:
Malfettone, Andrea;Soukupova, Jitka;Fabregat, Isabel
通讯作者:
Fabregat, Isabel
影响因子:
14.9
作者:
Ji Z;Ji H
通讯作者:
Ji H